Symbols / BDMD $1.95 +2.63% Baird Medical Investment Holdings Limited

Healthcare • Medical Devices • China • NCM
BDMD Chart
About

Baird Medical Investment Holdings Limited, together with its subsidiaries, engages in research, development, manufacturing, and sales of microwave ablation and other medical devices in the People's Republic of China. The company offers microwave ablation apparatus and needles; long microwave ablation needles; and fine microwave ablation needles for the treatment of benign and malignant tumors, including thyroid nodules, liver cancer, lung cancer, and breast lumps, as well as soft tissue ablation. It sells its products through third-party distributors. Baird Medical Investment Holdings Limited was founded in 2012 and is based in Guangzhou, China.

Fundamentals
Scroll to Statements
Sector Healthcare Industry Medical Devices Market Cap 71.62M
Enterprise Value 71.87M Income -3.17M Sales 31.86M
Book/sh 1.34 Cash/sh 0.09 Dividend Yield —
Payout 0.00% Employees 143 IPO —
P/E — Forward P/E — PEG —
P/S 2.25 P/B 1.46 P/C —
EV/EBITDA 78.17 EV/Sales 2.26 Quick Ratio 1.22
Current Ratio 1.71 Debt/Eq 63.33 LT Debt/Eq —
EPS (ttm) -0.11 EPS next Y — EPS Growth —
Revenue Growth -39.40% Earnings — ROA -0.20%
ROE -8.03% ROIC — Gross Margin 86.94%
Oper. Margin -131.30% Profit Margin -9.95% Shs Outstand 36.73M
Shs Float 7.73M Short Float 4.65% Short Ratio 0.11
Short Interest — 52W High 7.26 52W Low 0.76
Beta -1.16 Avg Volume 2.15M Volume 340.83K
Target Price — Recom None Prev Close $1.90
Price $1.95 Change 2.63%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
—
Mean price target
2. Current target
$1.95
Latest analyst target
3. DCF / Fair value
$1.23
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$1.95
Low
—
High
—
Mean
—
News
RSS: Latest BDMD news
Insider Transactions

No recent insider transactions.

Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total Revenue
37.04
+17.74%
31.46
-10.35%
35.09
+26.58%
27.72
Operating Revenue
37.04
+17.74%
31.46
-10.35%
35.09
+26.58%
27.72
Cost Of Revenue
4.38
+3.69%
4.23
-40.07%
7.05
+55.24%
4.54
Reconciled Cost Of Revenue
4.38
+3.69%
4.23
-40.07%
7.05
+55.24%
4.54
Gross Profit
32.65
+19.92%
27.23
-2.88%
28.04
+20.96%
23.18
Operating Expense
17.34
+18.95%
14.58
+11.87%
13.03
+29.19%
10.09
Research And Development
6.17
+44.43%
4.27
+10.77%
3.86
+271.08%
1.04
Selling General And Administration
9.96
+12.04%
8.89
-12.34%
10.15
-0.74%
10.22
Selling And Marketing Expense
4.06
+59.45%
2.55
-28.96%
3.59
+0.43%
3.57
General And Administrative Expense
5.90
-6.99%
6.35
-3.26%
6.56
-1.36%
6.65
Other Gand A
5.90
-6.99%
6.35
-3.26%
6.56
-1.36%
6.65
Other Operating Expenses
-0.00
+99.97%
-0.79
+42.42%
-1.38
-17.06%
-1.18
Total Expenses
21.72
+15.52%
18.80
-6.37%
20.08
+37.28%
14.63
Operating Income
15.32
+21.03%
12.65
-15.68%
15.01
+14.63%
13.09
Total Operating Income As Reported
15.32
+29.11%
11.86
-12.98%
13.63
+14.39%
11.92
EBITDA
16.17
+15.30%
14.03
-13.91%
16.29
+15.06%
14.16
Normalized EBITDA
16.17
+15.30%
14.03
-13.91%
16.29
+15.06%
14.16
Reconciled Depreciation
1.51
+9.17%
1.38
-6.07%
1.47
+5.02%
1.40
EBIT
14.66
+15.97%
12.65
-14.68%
14.82
+16.16%
12.76
Net Income
12.45
+18.09%
10.55
-16.09%
12.57
+24.58%
10.09
Pretax Income
14.09
+13.98%
12.36
-14.89%
14.52
+15.20%
12.61
Net Non Operating Interest Income Expense
-0.58
-102.75%
-0.28
+2.22%
-0.29
-91.77%
-0.15
Interest Expense Non Operating
0.58
+101.78%
0.29
-4.49%
0.30
+94.43%
0.15
Net Interest Income
-0.58
-102.75%
-0.28
+2.22%
-0.29
-91.77%
-0.15
Interest Expense
0.58
+101.78%
0.29
-4.49%
0.30
+94.43%
0.15
Interest Income Non Operating
0.00
-74.84%
0.00
-81.74%
0.01
+267.71%
0.00
Interest Income
0.00
-74.84%
0.00
-81.74%
0.01
+267.71%
0.00
Other Income Expense
-0.65
-6281.91%
-0.01
+94.75%
-0.19
+41.93%
-0.34
Other Non Operating Income Expenses
-0.65
-6281.91%
-0.01
+94.75%
-0.19
+41.93%
-0.34
Tax Provision
1.49
-12.45%
1.70
-2.63%
1.75
-27.89%
2.42
Tax Rate For Calcs
0.00
-22.98%
0.00
+14.41%
0.00
-37.35%
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
12.60
+18.20%
10.66
-16.57%
12.77
+25.45%
10.18
Net Income From Continuing Operation Net Minority Interest
12.45
+18.09%
10.55
-16.09%
12.57
+24.58%
10.09
Net Income From Continuing And Discontinued Operation
12.45
+18.09%
10.55
-16.09%
12.57
+24.58%
10.09
Net Income Continuous Operations
12.60
+18.20%
10.66
-16.57%
12.77
+25.45%
10.18
Minority Interests
-0.14
-28.99%
-0.11
+45.59%
-0.21
-119.47%
-0.09
Normalized Income
12.45
+18.09%
10.55
-16.09%
12.57
+24.58%
10.09
Net Income Common Stockholders
12.45
+18.09%
10.55
-16.09%
12.57
+24.58%
10.09
Diluted EPS
0.49
+18.74%
0.41
-16.09%
0.49
+24.58%
0.39
Basic EPS
0.49
+18.74%
0.41
-16.09%
0.49
+24.58%
0.39
Basic Average Shares
25.56
+0.00%
25.56
+0.00%
25.56
+0.00%
25.56
Diluted Average Shares
25.63
+0.29%
25.56
+0.00%
25.56
+0.00%
25.56
Diluted NI Availto Com Stockholders
12.50
+18.57%
10.55
-16.09%
12.57
+24.58%
10.09
Average Dilution Earnings
0.05
0.00
0.00
—
Provision For Doubtful Accounts
1.20
-45.45%
2.20
+450.00%
0.40
—
Line Item Trend 2024-12-31
Total Assets
77.96
Current Assets
61.42
Cash Cash Equivalents And Short Term Investments
2.97
Cash And Cash Equivalents
2.97
Cash Financial
2.97
Receivables
46.58
Accounts Receivable
46.58
Gross Accounts Receivable
50.57
Allowance For Doubtful Accounts Receivable
-3.99
Taxes Receivable
—
Inventory
1.30
Raw Materials
0.35
Work In Process
0.23
Finished Goods
0.72
Prepaid Assets
10.27
Other Current Assets
0.30
Total Non Current Assets
16.55
Net PPE
7.62
Gross PPE
12.21
Accumulated Depreciation
-4.59
Properties
0.00
Machinery Furniture Equipment
7.08
Other Properties
0.81
Leases
4.33
Goodwill And Other Intangible Assets
0.07
Goodwill
0.06
Other Intangible Assets
0.02
Non Current Deferred Assets
0.71
Non Current Deferred Taxes Assets
0.71
Non Current Prepaid Assets
8.02
Other Non Current Assets
0.12
Total Liabilities Net Minority Interest
38.20
Current Liabilities
34.62
Payables And Accrued Expenses
16.49
Payables
13.97
Accounts Payable
1.25
Other Payable
6.14
Current Accrued Expenses
2.52
Total Tax Payable
2.87
Income Tax Payable
0.08
Current Debt And Capital Lease Obligation
17.30
Current Debt
17.03
Other Current Borrowings
0.87
Current Capital Lease Obligation
0.26
Current Deferred Liabilities
0.84
Current Deferred Revenue
0.79
Total Non Current Liabilities Net Minority Interest
3.58
Long Term Debt And Capital Lease Obligation
3.58
Long Term Debt
3.44
Long Term Capital Lease Obligation
0.14
Stockholders Equity
39.66
Common Stock Equity
39.66
Capital Stock
0.00
Common Stock
0.00
Preferred Stock
0.00
Share Issued
35.73
Ordinary Shares Number
25.56
Treasury Shares Number
10.17
Additional Paid In Capital
11.44
Retained Earnings
26.76
Gains Losses Not Affecting Retained Earnings
1.45
Minority Interest
0.10
Other Equity Adjustments
1.45
Total Equity Gross Minority Interest
39.76
Total Capitalization
43.10
Working Capital
26.79
Invested Capital
60.14
Total Debt
20.88
Net Debt
17.51
Capital Lease Obligations
0.40
Net Tangible Assets
39.58
Tangible Book Value
39.58
Current Deferred Taxes Liabilities
0.05
Duefrom Related Parties Current
0.00
Dueto Related Parties Current
3.70
Line Of Credit
16.17
Preferred Stock Equity
0.00
Line Item Trend 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Operating Cash Flow
-6.31
-518.95%
-1.02
-309.88%
0.49
-90.75%
5.26
Cash Flow From Continuing Operating Activities
-6.31
-518.95%
-1.02
-309.88%
0.49
-90.75%
5.26
Net Income From Continuing Operations
12.60
+18.20%
10.66
-16.57%
12.77
+25.45%
10.18
Depreciation Amortization Depletion
1.51
+9.17%
1.38
-6.07%
1.47
+5.02%
1.40
Depreciation
1.51
+9.17%
1.38
-6.07%
1.47
+5.02%
1.40
Depreciation And Amortization
1.51
+9.17%
1.38
-6.07%
1.47
+5.02%
1.40
Provisionand Write Offof Assets
1.25
-46.72%
2.34
+432.83%
0.44
+89.75%
0.23
Deferred Tax
0.03
+106.05%
-0.54
-278.17%
-0.14
-215.80%
-0.05
Deferred Income Tax
0.03
+106.05%
-0.54
-278.17%
-0.14
-215.80%
-0.05
Operating Gains Losses
—
—
-0.01
-109.91%
0.05
Gain Loss On Sale Of PPE
0.00
0.00
+100.00%
-0.01
-109.91%
0.05
Change In Working Capital
-21.70
-46.05%
-14.86
-5.74%
-14.05
-113.89%
-6.57
Change In Receivables
-17.80
-83.99%
-9.67
+31.40%
-14.10
-304.09%
-3.49
Changes In Account Receivables
-17.80
-83.99%
-9.67
+34.80%
-14.84
-404.77%
-2.94
Change In Inventory
-0.19
-265.00%
0.11
-92.75%
1.57
+171.32%
-2.20
Change In Prepaid Assets
-4.84
+11.11%
-5.44
-57.70%
-3.45
-556.39%
-0.53
Change In Payables And Accrued Expense
1.31
+125.51%
0.58
-75.53%
2.38
+281.53%
0.62
Change In Accrued Expense
-1.57
-229.13%
1.21
-9.63%
1.34
+189.42%
0.46
Change In Payable
2.88
+556.79%
-0.63
-160.73%
1.04
+548.31%
0.16
Change In Account Payable
0.73
+113.10%
0.34
+438.36%
-0.10
-136.80%
0.27
Change In Other Working Capital
0.31
+279.17%
-0.17
-480.87%
0.05
+147.39%
-0.10
Change In Other Current Assets
0.00
+100.00%
-0.01
+98.97%
-0.88
-504.18%
-0.15
Change In Other Current Liabilities
-0.50
-96.15%
-0.25
-165.11%
0.39
+152.90%
-0.74
Investing Cash Flow
-2.85
-8.16%
-2.64
+55.44%
-5.92
-326.90%
-1.39
Cash Flow From Continuing Investing Activities
-2.85
-8.16%
-2.64
+55.44%
-5.92
-326.90%
-1.39
Net PPE Purchase And Sale
-2.85
-8.16%
-2.64
+55.10%
-5.88
-323.67%
-1.39
Purchase Of PPE
-2.85
-8.16%
-2.64
+55.35%
-5.91
-325.85%
-1.39
Sale Of PPE
0.00
0.00
-100.00%
0.03
+5722.64%
0.00
Capital Expenditure
-2.85
-8.16%
-2.64
+55.69%
-5.95
-329.08%
-1.39
Net Intangibles Purchase And Sale
0.00
0.00
+100.00%
-0.04
0.00
Purchase Of Intangibles
0.00
0.00
+100.00%
-0.04
0.00
Financing Cash Flow
10.72
+209.75%
3.46
-21.55%
4.41
+329.05%
-1.93
Cash Flow From Continuing Financing Activities
10.72
+209.75%
3.46
-21.55%
4.41
+329.05%
-1.93
Net Issuance Payments Of Debt
10.31
+130.58%
4.47
+0.32%
4.46
+5132.92%
-0.09
Issuance Of Debt
22.10
+81.92%
12.15
+34.03%
9.07
+154.25%
3.57
Repayment Of Debt
-11.79
-53.57%
-7.68
-66.65%
-4.61
-26.08%
-3.65
Long Term Debt Issuance
2.78
+9.07%
2.55
0.00
—
Long Term Debt Payments
-0.81
-315.77%
-0.19
0.00
+100.00%
-0.71
Net Long Term Debt Issuance
1.97
-16.20%
2.35
0.00
+100.00%
-0.71
Short Term Debt Issuance
19.32
+101.26%
9.60
+5.92%
9.07
+154.25%
3.57
Short Term Debt Payments
-10.98
-46.77%
-7.48
-62.44%
-4.61
-56.41%
-2.95
Net Short Term Debt Issuance
8.34
+293.77%
2.12
-52.49%
4.46
+618.99%
0.62
Net Common Stock Issuance
2.90
0.00
0.00
—
Common Stock Dividend Paid
—
—
0.00
+100.00%
-5.43
Cash Dividends Paid
—
—
0.00
+100.00%
-5.43
Net Other Financing Charges
-2.49
-146.38%
-1.01
-2080.39%
-0.05
-101.29%
3.59
Changes In Cash
1.55
+887.49%
-0.20
+80.72%
-1.02
-152.71%
1.94
Effect Of Exchange Rate Changes
-0.09
-2933.24%
-0.00
+98.96%
-0.30
-1704.48%
0.02
Beginning Cash Position
1.51
-11.72%
1.71
-43.57%
3.03
+182.92%
1.07
End Cash Position
2.97
+96.64%
1.51
-11.72%
1.71
-43.57%
3.03
Free Cash Flow
-9.17
-150.56%
-3.66
+33.10%
-5.47
-241.39%
3.87
Interest Paid Supplemental Data
0.50
+90.28%
0.26
+7.17%
0.24
+170.70%
0.09
Income Tax Paid Supplemental Data
1.84
-30.52%
2.64
+83.72%
1.44
-63.20%
3.91
Change In Income Tax Payable
2.15
+321.53%
-0.97
-185.31%
1.14
+1099.35%
-0.11
Change In Tax Payable
2.15
+321.53%
-0.97
-185.31%
1.14
+1099.35%
-0.11
Common Stock Issuance
2.90
0.00
0.00
—
Issuance Of Capital Stock
2.90
0.00
0.00
—
SEC Filings

No SEC filings found for this symbol (may be non-US or ticker not in SEC index).

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category